Substituted Resorcyclic Acid Compounds for AMPK Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new natural compounds that can mimic the beneficial effects of caloric restriction or increase lifespan by specifically targeting AMP-activated protein kinase (AMPK) without the potential side effects, as existing methods like dietary restriction are difficult to maintain and have unmet efficacy in activating AMPK directly.
Innovation Solution
The use of substituted resorcyclic acid compounds, such as those with specific R groups, which indirectly activate AMPK by causing perturbations in mitochondrial respiration, leading to increased AMP/ADP binding and activation of the AMPK enzyme, thereby improving metabolic pathways and longevity-related processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If dietary restriction is used to improve healthy ageing, then lifespan and resistance to age-related pathologies are increased, but the method is very difficult to maintain and follow
Solution Approach 1:
The patent uses small molecule compounds as intermediaries that mimic the beneficial effects of dietary restriction by directly activating AMPK, bypassing the need for actual caloric restriction. These compounds serve as a mediator between the desired health outcome and the difficult dietary intervention, providing the same protective effect without requiring sustained lifestyle changes
Solution Approach 2:
The invention changes the parameter from dietary intake (physical constraint) to pharmacological activation (chemical intervention). By using small molecules that directly bind to and activate AMPK, the system transforms the mechanism of action from indirect metabolic signaling through caloric restriction to direct enzymatic activation, thereby achieving the same biological outcome with improved ease of administration
2Reliability
If natural compounds are used to activate AMPK indirectly through mitochondrial perturbations, then AMPK is activated, but the mechanism causes perturbations in mitochondrial respiration and decrease in ATP levels
Solution Approach 1:
The patent employs small molecule compounds as intermediaries that directly bind to the AMPK binding site, eliminating the need for mitochondrial perturbations. These molecules serve as a cleaner mediator that activates AMPK through direct interaction rather than through the harmful pathway of ATP depletion and mitochondrial stress
Solution Approach 2:
The invention converts the indirect activation mechanism (which causes harmful mitochondrial perturbations) into a direct activation mechanism. By designing compounds that bind directly to AMPK, the harmful intermediate step of mitochondrial respiration disruption is eliminated, transforming a harmful pathway into a beneficial direct activation route
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These compounds have been shown to increase median and maximum lifespan, enhance mitochondrial energy, reduce oxidative stress, improve mobility, and protect against age-related pathologies in C. elegans, while also acting as autophagy inducers, potentially offering benefits in human healthspan and lifespan extension.
Implementation Method 1
indirectly activate AMPK by causing perturbations in mitochondrial respiration. This leads to a decrease in ATP levels of the cell and activation of AMPK through AMP/ADP binding to the nucleotide-binding site of the AMPK γ subunit
Data Source
AI summary
The present invention relates to composition comprising at least a compound having general formula (I) for use in (i) increasing resistance to age-related pathologies, (ii) improving a physiological state or disorder related to cell ageing, (iii) improving a physiological state linked to metabolic fatigue in one or more cells, (iv) increasing mitochondrial energy in one or more cells, (v) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (vi) improving mobility and/or (vii) improving healthspan and/or lifespan in an individual. The present invention also relates to a compound having general formula I for use as an autophagy inducer.